semaglutide tirzepatide conversion vs dosage chart dose and Charts: A Complete Guide Equivalent dosage when switched to – tirzepatide vs semaglutide dosage chart – conversion chart semaglutide to tirzepatide

As mentioned, there is no clear-cut, single best strategy based on current evidence when it comes to choosing when to prescribe antioxidants

Get in touch with us to learn how our products can make an impact on your practice.

Side-by-side compound comparison Receptor targets Tirzepatide GLP-1 + GIP (dual) Semaglutide GLP-1 only Retatrutide GLP-1 + GIP + Glucagon (triple) Half-life Tirzepatide ~5 days Semaglutide ~7 days Retatrutide ~6 days Dosing frequency Tirzepatide Once weekly Semaglutide Once weekly Retatrutide Once weekly Max studied dose Tirzepatide 15 mg / week Semaglutide 2.4 mg / week (Wegovy) Retatrutide 12 mg / week Peak weight loss Tirzepatide 22.5% (SURMOUNT-1, 72 wk) Semaglutide 15.8% (STEP-1, 68 wk) Retatrutide 24.2% (Phase 2, 48 wk) FDA status (June 2026) Tirzepatide Approved (T2D, obesity, OSA) Semaglutide Approved (T2D, obesity, CV risk) Retatrutide Investigational Phase 3 Head-to-head Tirzepatide 20.2% vs semaglutide 13.7% (SURMOUNT-5) Semaglutide Retatrutide Not yet head-to-head vs tirzepatide HFpEF benefit Tirzepatide Yes (SUMMIT, HR 0.62) Semaglutide Yes (STEP-HFpEF) Retatrutide Not yet studied Unique advantage Tirzepatide Best-in-class FDA-approved efficacy

Salmon Bites with Cucumber Salad (30g protein) Salmon is one of the best proteins you can eat rich in omega-3s and incredibly nutrient-dense per bite

Description Ipamorelin GHRP-2 CJC-1295 No DAC Peptide Combo UK Combining Ipamorelin, GHRP-2, and CJC-1295 No DAC creates a synergistic effect to enhance growth hormone release and support muscle growth

This opinion is well supported by the results of animal studies